AnandRathi

Sun Pharma Advanced Research Company Ltd Fundamental Analysis

Last Updated Date: 27 Aug 2026
194.75
+0.25 (+0.13%)

Sun Pharma Advanced Research Company Ltd (SPARC) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹6,320 crore.

Sun Pharma Advanced Research Company Ltd Overview

Market cap₹6,320 Crs
Volume70,823
Prev. Close₹194.50
Year range₹108.20 - ₹289.00
Total Value₹1,37,92,779.25
ISININE232I01014

Sun Pharma Advanced Research Company Ltd Fundamental Analysis

ROCE(TTM)81.08%
P/E Ratio (TTM)3.99
P/B Ratio4.74
Debt to Equity0.42
ROE116.39%
EPS (TTM)49.17
Dividend Yield0.00%
Book Value41.09
Profit Margin2298.06%
Operating Margin84.12%

Sun Pharma Advanced Research Company Ltd Historical Performance

1 Month Return-9.38%
6 Month Return53.23%
3 Year Return-10.91%
3 Month Return-12.14%
1 Year Return36.33%
5 Year Return-35.08%

Sun Pharma Advanced Research Company Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research